Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Zacks Investment Research on MSN
GPCR stock soars 102% on strong phase II obesity data for Aleniglipron
Shares of Structure Therapeutics GPCR skyrocketed 102.5% after the company reported positive top-line data from the ACCESS ...
Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...
TipRanks on MSN
IG Group enhances capital structure with share buyback
IG Group Holdings ( ($GB:IGG) ) just unveiled an update. IG Group Holdings plc announced the repurchase of 111,162 of its ordinary shares from ...
Set across 42 acres of hillside above Pochote Bay, the resort was conceived as a sequence of architectural responses to one ...
Herrington Management, a digital media company specializing in research-driven publishing and consumer insights, has released a comprehensive editorial brief examining the redemption value of ...
Real-time security clearances are becoming increasingly common in manufacturing of advanced-node semiconductors, where data ...
Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF)(Frankfurt:SC1P) ('Skyharbour” or the 'Company”) is pleased to announce ...
ASTER has plunged nearly 70% from its debut peak, with technicals pointing to further downside — yet aggressive buybacks and ...
The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...
You can prompt an AI model with a line of text, and it will generate most of the code needed to build an app, tool or website ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback